Funxional in form

Index Ventures' asset-focused investment strategy continues to bear fruit, with last week's somatotaxin deal by Funxional Therapeutics Ltd. marking the firm's third recent liquidity event from its asset-centric portfolio.

Last week, Boehringer Ingelheim GmbH agreed to acquire exclusive, worldwide rights to Funxional's portfolio of somatotaxins...